Product NDC: | 63323-329 |
Proprietary Name: | Bacitracin |
Non Proprietary Name: | BACITRACIN |
Active Ingredient(s): | 50000 [iU]/1 & nbsp; BACITRACIN |
Administration Route(s): | INTRAMUSCULAR |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63323-329 |
Labeler Name: | APP Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065116 |
Marketing Category: | ANDA |
Start Marketing Date: | 20030128 |
Package NDC: | 63323-329-30 |
Package Description: | 1 VIAL in 1 CARTON (63323-329-30) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
NDC Code | 63323-329-30 |
Proprietary Name | Bacitracin |
Package Description | 1 VIAL in 1 CARTON (63323-329-30) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
Product NDC | 63323-329 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | BACITRACIN |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAMUSCULAR |
Start Marketing Date | 20030128 |
Marketing Category Name | ANDA |
Labeler Name | APP Pharmaceuticals, LLC |
Substance Name | BACITRACIN |
Strength Number | 50000 |
Strength Unit | [iU]/1 |
Pharmaceutical Classes | Decreased Cell Wall Synthesis & Repair [PE] |